ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results

Author： Tullius S.G.   Pratschke J.   Strobelt V.   Kahl A.   Reinke P.   May G.   Frei U.   Neuhaus P.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.35, Iss.6, 2003-09, pp. : 2100-2101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A pilot study comparing basiliximab and anti-thymocyte globulin as induction therapy in sensitized renal allograft recipients

By Mariat C.   Afiani A.   Alamartine E.   Thibaudin D.   de Filippis J.P.   Berthoux F.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3192-3193

Elsevier

Access to resources Recommend Favorite

Perioperative administration of single, high-dose of ATG-Fresenius-S as an induction immunosuppressive therapy in cadaveric renal transplantation: preliminary results

By Samsel R.   Rowinski W.   Chmura A.   Wlodarczyk Z.   Wyzgal J.   Cieciura T.   Lagiewska B.   Pliszczynski J.   Korczak G.   Paczek L.   Walaszewski J.   Lao M.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 2952-2954

Elsevier

Access to resources Recommend Favorite

Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients

By Varghese Z.   Abudher M.N.   Fernando O.N.   Moorhead J.F.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2251-2253

Elsevier

Access to resources Recommend Favorite

Basiliximab versus ATG/ALG induction in pediatric renal transplants: comparison of herpes virus profile and rejection rates

By Acott P.D.   Lawen J.   Lee S.   Crocker J.F.S.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3180-3183

Elsevier

Access to resources Recommend Favorite

Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids

By Lebranchu Y.   Aubert P.   Bayle F.   Bedrossian J.   Berthoux F.   Bourbigot B.   Buchler M.   Chalopin J.M.   Deteix P.   Glotz D.   Huraut De Ligny B.   Kessler M.   Lang P.   Lefrancois N.   Le Pogamp P.   Moulin B.   Mourad G.   Olmer M.   Sraer J.D.   Touchard G.   Toupance O.   Wolf P.   Puget S.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 396-397

Elsevier

Access to resources Recommend Favorite